At $2.1M, Novartis gene therapy will be world’s most expensive drug

At $2.1M, Novartis gene therapy will be world’s most expensive drug

At $2.1 million, newly approved Novartis gene therapy will be world’s most expensive drug

By ADAM FEUERSTEIN

RUBY WALLAU FOR STAT

Known as Zolgensma, the gene therapy treats children under two years of age with spinal muscular atrophy, an inherited neuromuscular disease.

READ MORE